US4264599A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Piperidino-propanols
Assignee: Novartis Corp
•
Filing: 1978-07-03
•
Granted: 1981-04-28
•
Expires: 1998-07-03
Abstract
Abstract The invention relates to novel piperidino-propanols, especially 1-(3-heterocyclyloxy-2-hydroxy-propanol)-4-(N-diazcyclyl)-piperidines of the formula <IMAGE> (I) in which R1 is a substituted or unsubstituted heteroaryl radical, R2 is hydrogen or a substituted or unsubstituted aliphatic, cycloaliphatic, cycloaliphatic-aliphatic or araliphatic hydrocarbon radical or an acyl radical and alk is lower alkylene which separates the two nitrogen atoms from one another by 2 or 3 carbon atoms, or is a substituted or unsubstituted 1,2-phenylene radical, and salts thereof, as well as processes for their preparation, and also to pharmaceutical preparations containing these compounds and the use thereof, preferably in the form of pharmaceutical preparations as antihypertensive agents, antitachycardiac agents and alpha -sympathicolytic agents.
Inventors
- 👤 Kurt Eichenberger
- 👤 Hans Kuhnis
- 👤 Franz Ostermayer
- 👤 Herbert Schroter
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 06:24
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/62; C07D213/69; C07D209/00; C07D209/02; C07D209/04; C07D209/08; C07D211/00; C07D211/04; C07D211/06; C07D211/36; C07D211/56; C07D211/58; C07D213/63; C07D213/65
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
107 words
A piperidino propanol of the formula ##STR13## wherein R 1 is 2-pyrazinyl, pyridyl or indolyl, which is unsubstituted or substituted by lower alkyl, lower alkoxy, lower alkylthio, halogen with an atomic number of not more than 35 or nitro, R 2 is hydrogen, lower alkyl, cycloalkyl having 3 to 8 carbon atoms or phenyl-lower alkyl which is unsubstituted or substituted in the phenyl moiety by lower alkyl, lower alkoxy or halogen with an atomic number of not more than 35, and alk is lower alkylene have 2-3 carbon atoms, which separates the two nitrogen atoms by 2-3 carbon atoms, and a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim
107 words
A piperidino propanol of the formula ##STR13## wherein R 1 is 2-pyrazinyl, pyridyl or indolyl, which is unsubstituted or substituted by lower alkyl, lower alkoxy, lower alkylthio, halogen with an atomic number of not more than 35 or nitro, R 2 is hydrogen, lower alkyl, cycloalkyl having 3 to 8 carbon atoms or phenyl-lower alkyl which is unsubstituted or substituted in the phenyl moiety by lower alkyl, lower alkoxy or halogen with an atomic number of not more than 35, and alk is lower alkylene have 2-3 carbon atoms, which separates the two nitrogen atoms by 2-3 carbon atoms, and a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim
74 words
Piperidino propanols according to claim 1, wherein R 1 is 2-pyrazinyl, pyridyl or indolyl, which is unsubstituted or substituted by lower alkyl, lower alkoxy, lower alkylthio, halogen with an atomic number of not more than 35 and/or nitro, R 2 is hydrogen, lower alkyl or phenyl-lower alkyl and alk is lower alkylene having 2-3 carbon atoms, which separates the two nitrogen atoms by 2-3 carbon atoms, and a pharmaceutically acceptable acid addition salt thereof.
Claim 4
Dependent Claim
78 words
Piperidino propanols according to claim 1, wherein R 1 is 4-indolyl, 2-pyrazinyl or pyridyl, which in the ortho-position relative to the linking carbon atom and/or nitrogen atom can be substituted by lower alkyl, lower alkoxy, lower alkylthio, halogen with an atomic number of not more than 35 or nitro, and can contain further substituents of this type, R 2 is hydrogen, lower alkyl or phenyl-lower alkyl and alk is ethylene, and a pharmaceutically acceptable acid addition salt thereof.
Claim 5
Dependent Claim
57 words
Piperidino propanols according to claim 1, wherein R 1 is 2-pyrazinyl which is unsubstituted or substituted in the 3-position by lower alkyl, lower alkoxy, lower alkylthio, halogen with an atomic number of not more than 35 or nitro, R 2 is hydrogen or lower alkyl and alk is ethylene, and a pharmaceutically acceptable acid addition salt thereof.
Claim 6
Dependent Claim
16 words
A compound according to claim 1, which is 1-{1-[2-hydroxy-3-(3-methoxy-2-pyrazinyloxy)-propyl]-4-piperidyl}-imidazolidin-2-one and its pharmaceutically acceptable acid addition salts.
Claim 7
Dependent Claim
15 words
A compound according to claim 1, which 4-{3-[4-(2-oxo-3-imidazolidinyl)-1-piperidyl]-2-hydroxy-1-propoxy}-2-methyl-1H-indole and its pharmaceutically acceptable acid addition salts.
Claim 8
Dependent Claim
16 words
A compound according to claim 1, which is 4-{3-[4-(1-methyl-2-oxo-3-imidazolidinyl)-1-piperidyl]-2-hydroxy-1-propoxy}-2-methyl-1H-indole and its pharmaceutically acceptable acid addition salts.
Claim 9
Dependent Claim
38 words
A pharmaceutical composition useful in the treatment of hypertension in a warmblooded animal comprising a therapeutically effective amount of a compound according to claim 1 or of a pharmaceutically acceptable acid addition salt thereof with a pharmaceutical carrier.
Claim 10
Dependent Claim
18 words
A pharmaceutical composition according to claim 8, which contains 1-{1-[2-hydroxy-3-(3-methoxy-2-pyrazinyloxy)-propyl]-4-piperidyl}-imidazolidin-2-one or a pharmaceutically acceptable acid addition salt thereof.
Claim 11
Dependent Claim
18 words
A pharmaceutical composition according to claim 8, which contains 4-{3-[4-(2-oxo-3-imidazolidinyl)-1-piperidyl]-2-hydroxy-1-propoxy}-2-methyl-1H-indole or a pharmaceutically acceptable acid addition salt thereof.
Claim 12
Dependent Claim
18 words
A pharmaceutical composition according to claim 8, which contains 4-{3-[4-(1-methyl-2-oxo-3-imidazolidinyl)-1-piperidyl]-2-hydroxy-1-propoxy}-2-methyl-1H-indole or a pharmaceutically acceptable acid addition salt thereof.
Claim 13
Dependent Claim
34 words
A method of treating hypertension in a warmblooded animal which comprises administering to said animal a therapeutically effective amount of a compound according to claim 1, or a pharmaceutically acceptable acid addition salt thereof.
Claim 14
Dependent Claim
23 words
A method according to claim 12, which comprises administering a therapeutically effective amount of 1-{1-[2-hydroxy-3-(3-methoxy-2-pyrazinyloxy)-propyl]-4-piperidyl}-imidazoldidin-2-one, or a pharmaceutically acceptable acid addition salt thereof.
Claim 15
Dependent Claim
23 words
A method according to claim 12, which comprises administering a therapeutically effective amount of 4-{3-[4-(2-oxo-3-imidazolidinyl)-1-piperidyl]-2-hydroxy-1-propoxy}-2-methyl-1H-indole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 16
Dependent Claim
23 words
A method according to claim 12, which comprises administering a therapeutically effective amount of 4-{3-[4-(1-methyl-2-oxo-3-imidazolidinyl)-1-piperidyl]-2-hydroxy-1-propoxy}-2-methyl-1H-indole, or a pharmaceutically acceptable acid addition salt thereof.
References Cited (Backward Citations)
US3494932A
Cited
US3946009A
Cited
US3956335A
Cited
US4075208A
Cited
US4075335A
Cited
US4038279A
Cited
US4115575A
Cited
US4027027A
Cited
US4134983A
Cited
US4144344A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-04-27 | 1984-10-27 | 1985-04-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-04-27 | 1988-10-27 | 1989-04-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-04-27 | 1992-10-27 | 1993-04-28 | $7700.00 | Window Closed / Lapsed |